# NCT05700461 (NCT05700461)

> Drug Screening Using Novel IMD in Renal Cell Carcinoma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05700461
- Phase: PHASE1
- Status: RECRUITING
- Sponsor: Oliver Jonas
- Conditions: Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Kidney Cancer
- Interventions: Implantable Microdevice (IMD)
- Enrollment: 20
- Primary outcome: Safety of microdevice implantation
- Primary outcome: Number of Patients with Feasible Microdevice Procedure

## Indexed commentary on NCT05700461 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct05700461